Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Aug 27;22(9):63.
doi: 10.1007/s11906-020-01078-6.

Endothelial Dysfunction in COVID-19: Lessons Learned from Coronaviruses

Affiliations
Review

Endothelial Dysfunction in COVID-19: Lessons Learned from Coronaviruses

Eleni Gavriilaki et al. Curr Hypertens Rep. .

Abstract

To review current literature on endothelial dysfunction with previous coronaviruses, and present available data on the role of endothelial dysfunction in coronavirus disease-2019 (COVID-19) infection in terms of pathophysiology and clinical phenotype RECENT FINDINGS: Recent evidence suggests that signs and symptoms of severe COVID-19 infection resemble the clinical phenotype of endothelial dysfunction, implicating mutual pathophysiological pathways. Dysfunction of endothelial cells is believed to mediate a variety of viral infections, including those caused by previous coronaviruses. Experience from previous coronaviruses has triggered hypotheses on the role of endothelial dysfunction in the pathophysiology of SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2), which are currently being tested in preclinical and clinical studies. Endothelial dysfunction is the common denominator of multiple clinical aspects of severe COVID-19 infection that have been problematic for treating physicians. Given the global impact of this pandemic, better understanding of the pathophysiology could significantly affect management of patients.

Keywords: COVID-19; Complement; Endothelial dysfunction; SARS-COV-2; Thrombosis; Thrombotic microangiopathy.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest relevant to this manuscript.

Figures

Fig. 1
Fig. 1
Schematic representation of endothelial dysfunction in COVID-19

Similar articles

Cited by

References

    1. Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, Mehra MR, Schuepbach RA, Ruschitzka F, Moch H. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395(10234):1417–1418. doi: 10.1016/S0140-6736(20)30937-5. - DOI - PMC - PubMed
    1. Steinberg BE, Goldenberg NM, Lee WL. Do viral infections mimic bacterial sepsis? The role of microvascular permeability: a review of mechanisms and methods. Antivir Res. 2012;93(1):2–15. doi: 10.1016/j.antiviral.2011.10.019. - DOI - PubMed
    1. Goeijenbier M, van Wissen M, van de Weg C, Jong E, Gerdes VE, Meijers JC, et al. Review: viral infections and mechanisms of thrombosis and bleeding. J Med Virol. 2012;84(10):1680–1696. doi: 10.1002/jmv.23354. - DOI - PMC - PubMed
    1. Rajendran P, Rengarajan T, Thangavel J, Nishigaki Y, Sakthisekaran D, Sethi G, et al. The vascular endothelium and human diseases. Int J Biol Sci. 2013;9(10):1057–1069. doi: 10.7150/ijbs.7502. - DOI - PMC - PubMed
    1. Michiels C. Endothelial cell functions. J Cell Physiol. 2003;196(3):430–443. doi: 10.1002/jcp.10333. - DOI - PubMed

Publication types

LinkOut - more resources